Would you recommend stem cell transplant or gene therapy for a patient with CML and sickle cell disease currently on imatinib with worsening anemia?
1 Answer
Mednet MemberInvited Expert
Medical Oncology · Massachusetts General Hospital
Answered on
That's a great question. The first question to figure out is what is the status of the CML? If the patient is in a molecular remission on imatinib, I think it's important to understand why the patient has worsening anemia and do a work up. If the patient has anemia due to the TKI, can consider dose ...
Join for free or sign in to see the full answer